中国危重病急救医学
中國危重病急救醫學
중국위중병급구의학
CHINESE CRITICAL CARE MEDICINE
2009年
11期
656-659
,共4页
杨小芳%熊建文%王志禄%李俨%许哲通%崔丽君%王锋%谈丽丽%张丽
楊小芳%熊建文%王誌祿%李儼%許哲通%崔麗君%王鋒%談麗麗%張麗
양소방%웅건문%왕지록%리엄%허철통%최려군%왕봉%담려려%장려
促红细胞生成素%内皮细胞%凋亡%氧化低密度脂蛋白
促紅細胞生成素%內皮細胞%凋亡%氧化低密度脂蛋白
촉홍세포생성소%내피세포%조망%양화저밀도지단백
erythropoietin%endothelial cell%apoptosis%oxidized-low density lipoprotein
目的 建立氧化低密度脂蛋白(ox-LDL)诱导培养人脐静脉内皮细胞(HUVECs)凋亡模型,探讨促红细胞生成素(EPO)对ox-LDL诱导HUVECs凋亡的影响.方法 取体外培养3~6代的HUVECs用于实验.实验分为两组:一组细胞予以不同浓度(6.25、50、100 kU/L)重组人促红细胞生成素(rhEPO)预处理24 h,再加入100 mg/L ox-LDL孵育48 h;另一组细胞加入反式或顺式LOX-1 mRNA预处理24 h,再加入 100 mg/L 的ox-LDL孵育12 h.采用存活率、凋亡率和Bcl-2/Bax比值评价细胞凋亡情况.结果 与ox-LDL组比较,随rhEPO浓度的递增,细胞存活率增高,细胞凋亡率降低,凋亡蛋白Bcl-2/Bax比值增高(P均<0.05),呈剂量依赖性.反式LOX-1 mRNA(0.5 μmol/L)预处理组凋亡蛋白Bcl-2/Bax比值较ox-LDL组明显增高(P<0.05);顺式LOX-1 mRNA(0.5 μmol/L)预处理组Bcl-2/Bax比值与ox-LDL组则无明显差异.结论 ox-LDL可以诱导HUVECs凋亡,并且通过LOX-1 mRNA来调节,rhEPO可增高Bcl-2/Bax比值,抑制ox-LDL诱导的HUVECs凋亡.
目的 建立氧化低密度脂蛋白(ox-LDL)誘導培養人臍靜脈內皮細胞(HUVECs)凋亡模型,探討促紅細胞生成素(EPO)對ox-LDL誘導HUVECs凋亡的影響.方法 取體外培養3~6代的HUVECs用于實驗.實驗分為兩組:一組細胞予以不同濃度(6.25、50、100 kU/L)重組人促紅細胞生成素(rhEPO)預處理24 h,再加入100 mg/L ox-LDL孵育48 h;另一組細胞加入反式或順式LOX-1 mRNA預處理24 h,再加入 100 mg/L 的ox-LDL孵育12 h.採用存活率、凋亡率和Bcl-2/Bax比值評價細胞凋亡情況.結果 與ox-LDL組比較,隨rhEPO濃度的遞增,細胞存活率增高,細胞凋亡率降低,凋亡蛋白Bcl-2/Bax比值增高(P均<0.05),呈劑量依賴性.反式LOX-1 mRNA(0.5 μmol/L)預處理組凋亡蛋白Bcl-2/Bax比值較ox-LDL組明顯增高(P<0.05);順式LOX-1 mRNA(0.5 μmol/L)預處理組Bcl-2/Bax比值與ox-LDL組則無明顯差異.結論 ox-LDL可以誘導HUVECs凋亡,併且通過LOX-1 mRNA來調節,rhEPO可增高Bcl-2/Bax比值,抑製ox-LDL誘導的HUVECs凋亡.
목적 건립양화저밀도지단백(ox-LDL)유도배양인제정맥내피세포(HUVECs)조망모형,탐토촉홍세포생성소(EPO)대ox-LDL유도HUVECs조망적영향.방법 취체외배양3~6대적HUVECs용우실험.실험분위량조:일조세포여이불동농도(6.25、50、100 kU/L)중조인촉홍세포생성소(rhEPO)예처리24 h,재가입100 mg/L ox-LDL부육48 h;령일조세포가입반식혹순식LOX-1 mRNA예처리24 h,재가입 100 mg/L 적ox-LDL부육12 h.채용존활솔、조망솔화Bcl-2/Bax비치평개세포조망정황.결과 여ox-LDL조비교,수rhEPO농도적체증,세포존활솔증고,세포조망솔강저,조망단백Bcl-2/Bax비치증고(P균<0.05),정제량의뢰성.반식LOX-1 mRNA(0.5 μmol/L)예처리조조망단백Bcl-2/Bax비치교ox-LDL조명현증고(P<0.05);순식LOX-1 mRNA(0.5 μmol/L)예처리조Bcl-2/Bax비치여ox-LDL조칙무명현차이.결론 ox-LDL가이유도HUVECs조망,병차통과LOX-1 mRNA래조절,rhEPO가증고Bcl-2/Bax비치,억제ox-LDL유도적HUVECs조망.
Objective To explore the protective effect of erythropoietin (EPO) against oxidized-low density lipoprotein (ox-LDL)-induced apoptosis in human umbilical vein endothelial cells (HUVECs) in an ox-LDL induced apoptosis model. Methods Thirdsixth passage of cultured HUVECs were used,and they were divided into two groups. The cells were pretreated with different concentrations (6.25,50,100 kU/L) of recombinant human erythropoietin (rhEPO) for 24 hours,then they were exposed to ox-LDL (100 mg/L) for 48 hours;another group of cells were pretreated with antisense to 0.5 μmol/L LOX-1 mRNA or 0.5 μmol/L sense for 24 hours,and then HUVECs were exposed to ox-LDL (100 mg/L) for 12 hours. Apoptosis was assessed by the apoptosis ratio,cell viability,and Bcl-2/Bax ratio. Results As compared to untreated controls,pretreatment with rhEPO led to increased cell survival of HUVECs and decreased cell apoptosis in a dose-dependent manner (all P<0.05). Consistently,the Bcl-2/Bax ratios were also increased in a similar fashion. The ratio of apoptosis protein Bcl-2/Bax was increased in the antisense LOX-1 mRNA group than that of ox-LDL group (P<0.05),but the one in the sense LOX-1 mRNA group was not significantly different from that of ox-LDL group. Conclusion The ox-LDL can induce apoptosis in HUVECs by regulating LOX-1 mRNA,and rhEPO can increase Bcl-2/Bax ratio and inhibite ox-LDL-induced apoptosis of HUVECs.